The Discounted Cash Flow (DCF) valuation of Exagen Inc (XGN) is (22.06) USD. With the latest stock price at 6.65 USD, the upside of Exagen Inc based on DCF is -431.7%.
Based on the latest price of 6.65 USD and our DCF valuation, Exagen Inc (XGN) is a sell. selling XGN stocks now will result in a potential gain of 431.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 8.1% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (74.83) - (13.41) | (22.06) |
| Upside | -1225.3% - -301.7% | -431.7% |